Standard of Care sensibility: Anti-PD1 = yes / Anti PDL1 = yes (12,5 mg/kg).
Acquired resistance to: PD1/PDL1
Tumour model
Standard of Care sensibility: Anti-PD1 = yes / Anti PDL1 = yes (12,5 mg/kg).
Acquired resistance to: PD1/PDL1
Tell us about your compound and your endpoints. Our team confirms feasibility, timelines and study design before any commitment.
Other models sharing the same tissue of origin.